仿制药生产商Viatris Inc.（VTRS）今日盘前大涨5.71%，主要受益于公司发布的强劲第二季度财报。
根据公司公告，Viatris第二季度每股收益达到0.62美元，显著高于分析师预期的0.56美元。季度营收为35.8亿美元，同样超过市场预期的34.7亿美元。这一亮眼的业绩表现提振了投资者信心，推动股价上涨。
值得注意的是，尽管面临行业挑战，Viatris仍然重申了其2025年的财务指引。公司预计2025年收入将在135亿至140亿美元之间，全年每股收益预期维持在2.16美元至2.30美元区间。这一坚定的展望进一步增强了市场对公司长期发展前景的信心。然而，投资者也应当注意，在此次上涨之前，Viatris股价年内已累计下跌29.7%，显示出该公司仍面临一定的市场压力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.